| pubmed-article:11007839 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C0022671 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C0001617 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C0010592 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C0035015 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C0205178 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C1882923 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C1548437 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C1708528 | lld:lifeskim |
| pubmed-article:11007839 | lifeskim:mentions | umls-concept:C0003442 | lld:lifeskim |
| pubmed-article:11007839 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:11007839 | pubmed:dateCreated | 2000-10-30 | lld:pubmed |
| pubmed-article:11007839 | pubmed:abstractText | Despite their well-known side-effects, corticosteroids (Cs) are currently used after kidney transplantation. Avoidance of Cs may improve patient quality of life and eventual long-term survival. We report on a regimen using antithymocyte globulin (ATG) and mycophenolate mofetil (MMF) for induction, and cyclosporin (CsA) plus MMF for maintenance treatment of recipients of primary kidney transplantation. | lld:pubmed |
| pubmed-article:11007839 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11007839 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11007839 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11007839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11007839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11007839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11007839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11007839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11007839 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11007839 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11007839 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:11007839 | pubmed:issn | 0931-0509 | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:SoulillouJ... | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:HourmantMM | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:MoreauAA | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:DantalJJ | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:BlanchoGG | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:CantarovichDD | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:Giral-ClasseM... | lld:pubmed |
| pubmed-article:11007839 | pubmed:author | pubmed-author:LeratLL | lld:pubmed |
| pubmed-article:11007839 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11007839 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:11007839 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11007839 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11007839 | pubmed:pagination | 1673-6 | lld:pubmed |
| pubmed-article:11007839 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:meshHeading | pubmed-meshheading:11007839... | lld:pubmed |
| pubmed-article:11007839 | pubmed:year | 2000 | lld:pubmed |
| pubmed-article:11007839 | pubmed:articleTitle | Prevention of acute rejection with antithymocyte globulin, avoiding corticosteroids, and delaying cyclosporin after renal transplantation. | lld:pubmed |
| pubmed-article:11007839 | pubmed:affiliation | Department of Nephrology and Clinical Immunology, Institut de Transplantation et de Recherche en Transplantation (ITERT), Nantes, France. | lld:pubmed |
| pubmed-article:11007839 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11007839 | lld:pubmed |
